SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-024688
Filing Date
2018-04-11
Accepted
2018-04-11 18:15:00
Documents
2
Period of Report
2018-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1568
2 EX-24 DOCUMENT attachment1.htm EX-24 3604
  Complete submission text file 0001209191-18-024688.txt   6799
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-769-9145
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DARE BIOSCIENCE, INC. 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address
Grossman Jessica D. (Reporting) CIK: 0001736781 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 18750903